Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.

Wakita K, Tetsu O, McCormick F.

Cancer Res. 2001 Feb 1;61(3):854-8.

2.

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW.

Science. 1997 Mar 21;275(5307):1787-90.

3.

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.

Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H.

Science. 1997 Mar 21;275(5307):1784-7.

4.

The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.

Shih IM, Yu J, He TC, Vogelstein B, Kinzler KW.

Cancer Res. 2000 Mar 15;60(6):1671-6.

5.
6.

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

Tetsu O, McCormick F.

Nature. 1999 Apr 1;398(6726):422-6.

PMID:
10201372
7.

Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis.

Takahashi M, Fujita M, Furukawa Y, Hamamoto R, Shimokawa T, Miwa N, Ogawa M, Nakamura Y.

Cancer Res. 2002 Oct 15;62(20):5651-6.

8.
9.

Identification of Tcf4 residues involved in high-affinity beta-catenin binding.

Omer CA, Miller PJ, Diehl RE, Kral AM.

Biochem Biophys Res Commun. 1999 Mar 24;256(3):584-90.

PMID:
10080941
10.
11.

Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.

Faux MC, Ross JL, Meeker C, Johns T, Ji H, Simpson RJ, Layton MJ, Burgess AW.

J Cell Sci. 2004 Jan 26;117(Pt 3):427-39. Epub 2003 Dec 16.

12.

beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.

Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, Wiesmann M, Garcia PD, Fuller JH, Chan V, Randazzo F, Gundel R, Warren RS, Escobedo J, Aukerman SL, Taylor RN, Fantl WJ.

Cancer Res. 2003 Jun 15;63(12):3145-53.

13.

Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin.

Fujita M, Furukawa Y, Nagasawa Y, Ogawa M, Nakamura Y.

Cancer Res. 2000 Dec 1;60(23):6683-7.

14.

Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.

Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P.

Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3046-50.

15.

APC truncation and increased beta-catenin levels in a human breast cancer cell line.

Schlosshauer PW, Brown SA, Eisinger K, Yan Q, Guglielminetti ER, Parsons R, Ellenson LH, Kitajewski J.

Carcinogenesis. 2000 Jul;21(7):1453-6.

PMID:
10874025
16.
17.

Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma.

Rockman SP, Currie SA, Ciavarella M, Vincan E, Dow C, Thomas RJ, Phillips WA.

J Biol Chem. 2001 Nov 30;276(48):45113-9. Epub 2001 Sep 25.

18.

Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.

Takahashi M, Nakamura Y, Obama K, Furukawa Y.

Int J Oncol. 2005 Dec;27(6):1483-7.

PMID:
16273202
19.

Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone.

Natsume H, Sasaki S, Kitagawa M, Kashiwabara Y, Matsushita A, Nakano K, Nishiyama K, Nagayama K, Misawa H, Masuda H, Nakamura H.

Biochem Biophys Res Commun. 2003 Sep 19;309(2):408-13.

PMID:
12951064
20.

Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.

Yamada T, Takaoka AS, Naishiro Y, Hayashi R, Maruyama K, Maesawa C, Ochiai A, Hirohashi S.

Cancer Res. 2000 Sep 1;60(17):4761-6.

Supplemental Content

Support Center